PHYTONADIONE
NDC 0574-1850, phytonadione, tablet, from Padagis US LLC.
- Product NDC
- 0574-1850
- Status
- Listed
- Labeler
- Padagis US LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220454
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0574-1850 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PHYTONADIONE5 mg/1
Pharmacologic classes
Increased Prothrombin Activity [PE]; Reversed Anticoagulation Activity [PE]; Vitamin K [CS]; Vitamin K [EPC]; Warfarin Reversal Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0574-1850-30 | 00574185030 | 1 BOTTLE in 1 CARTON (0574-1850-30) / 30 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/68701a07-2921-4443-bff3-76e261a9eb18
Use it
Look up 0574-1850 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0574-1850 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0574-1850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.